$3,303,232
＋56.1%
Executive Vice President Chief Clinical Innov Officer
2024
$2.6M org
40 hrs/wk
$683k other
--
Executive Vice President Chief Clinical Innov Officer at Baylor Scott & White Holdings
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Alejandro Arroliga, M.D. has been listed as an employee of Baylor Scott & White Holdings in Form 990 filings since at least fiscal year 2016. Total compensation for Alejandro Arroliga, M.D. has increased by 246.6% from 2016 to 2024.